Speaker illustration

Doctor Arman Qamar

Brigham and Women's Hospital, Boston (United States of America)

Efficacy and safety of edoxaban vs. warfarin in patients with atrial fibrillation and hepatic disease: Insights from the ENGAGE AF-TIMI 48 trial

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb